Antioxidant enzymes activity in polymorphonuclear leukocytes in chronic renal failure. 1995

R Shurtz-Swirski, and E Mashiach, and B Kristal, and T Shkolnik, and S M Shasha
Eliachar Research Laboratory, Western Galilee Hospital, Nahariya, Israel.

In the present study, activity of polymorphonuclear leukocyte (PMNL) intracellular antioxidant enzymes, i.e. catalase, superoxide dismutase (SOD) and glutathione peroxidase (GPX), was assessed in CRF patients on hemodialysis (HD), or continuous ambulatory peritoneal dialysis (CAPD) and in healthy controls. The activity of SOD and GPX was reduced in HD and in CAPD (SOD: by 34.2 and 42%, respectively, and GPX 66 vs. 42%, respectively, taking the activity in normal controls as 100%). Catalase activity, on the other hand, was significantly augmented (298 and 175%, respectively) as compared to the healthy controls. This impairment in antioxidant enzymes activity, involved in the respiratory burst and phagocytosis, may contribute to the understanding of the reduced bactericidal ability of PMNL activity found in these patients.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D002374 Catalase An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. Catalase A,Catalase T,Manganese Catalase,Mn Catalase
D005260 Female Females

Related Publications

R Shurtz-Swirski, and E Mashiach, and B Kristal, and T Shkolnik, and S M Shasha
January 1989, Nephron,
R Shurtz-Swirski, and E Mashiach, and B Kristal, and T Shkolnik, and S M Shasha
January 1971, Texas reports on biology and medicine,
R Shurtz-Swirski, and E Mashiach, and B Kristal, and T Shkolnik, and S M Shasha
January 1988, Basic life sciences,
R Shurtz-Swirski, and E Mashiach, and B Kristal, and T Shkolnik, and S M Shasha
January 1988, Nephron,
R Shurtz-Swirski, and E Mashiach, and B Kristal, and T Shkolnik, and S M Shasha
January 1968, Annales medicinae experimentalis et biologiae Fenniae,
R Shurtz-Swirski, and E Mashiach, and B Kristal, and T Shkolnik, and S M Shasha
February 2003, Yonsei medical journal,
R Shurtz-Swirski, and E Mashiach, and B Kristal, and T Shkolnik, and S M Shasha
August 2004, Pediatric nephrology (Berlin, Germany),
R Shurtz-Swirski, and E Mashiach, and B Kristal, and T Shkolnik, and S M Shasha
January 2005, Clinical hemorheology and microcirculation,
R Shurtz-Swirski, and E Mashiach, and B Kristal, and T Shkolnik, and S M Shasha
January 2001, The American journal of cardiology,
R Shurtz-Swirski, and E Mashiach, and B Kristal, and T Shkolnik, and S M Shasha
April 1988, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!